To address the molecular mechanisms underlying the noted upregulation and oncogenic role of PSG9 in breast cancer cells, we analyzed the promoter sequence of the human PSG9 gene within 1‐kb region upstream from the transcriptional start site. The gene discussed is PSG9; the disease is breast carcinoma.